knowledge -WSS

knowledge

author：leisure time 2025-09-06 02:15:34 - browse：4

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Late stage cancers on the rise after pandemic delayed screenings

WSS

EU moves toward latest gene techniques in food production to counter climate change, shortages

Search warrant issued in 1996 disappearance of Kristin Smart

Israel withdraws forces after 2

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

5 shark bites reported on Long Island as officials deploy surveillance drones

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

ChatGPT in medicine: STAT answers readers' burning questions

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

DIEP, the 'gold standard' of breast reconstruction, is under threat

Heart disease in astronauts blamed on cosmic radiation

Psychedelics group wrestles with new pharma identity

5 shark bites reported on Long Island as officials deploy surveillance drones

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CDC recommends RSV monoclonal antibody for infants

Drug repurposing or repositioning? The language matters

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Wikipedia

Flint parents haunted by uncertainty, fears of lead poisoning

FDA scientists endorse Pfizer/BioNTech Covid

Following judge's order, DOJ releases slightly less

Late stage cancers on the rise after pandemic delayed screenings

Group behind ProMed defends move to subscription

Pharma showers House GOP doctor with campaign cash

focus

focus

hotspot

knowledge